
Intra-Cellular Therapies (ITCI)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Intra-Cellular Therapies (ITCI) Stock
Start investing in Intra-Cellular Therapies (ITCI)
About Intra-Cellular Therapies (ITCI)
Market cap | $14.05B |
Today's volume | — |
Revenue (TTM) | $680.85M |
Avg. daily volume | 3.22M |
EBITDA (TTM) | -$116.21M |
Open | — |
Price / earnings ratio | -182.70x |
Today's range | — |
Debt / equity | 1.48x |
52 week range | $64.09 - $131.98 |
5 year debt / equity | 2.76x |
Beta (LTM) | 0.15x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | 6.36x |
Ex-dividend date | — |
Next earnings | Jul 7, 2025 |
Dividend payable date | — |
Intra-Cellular Therapies Stock Rating
Intra-Cellular Therapies Stock News
View all



Frequently Asked Questions (FAQ)
How to buy ITCI stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in ITCI stock
Navigate to the Explore page. Then, type ITCI into the search bar. When you see ITCI stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased ITCI stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Intra-Cellular Therapies Stock Earnings
The value each ITCI share was expected to gain vs. the value that each ITCI share actually gained.
Intra-Cellular Therapies (ITCI) reported Q4 2024 earnings per share (EPS) of -$0.16, missing estimates of -$0.12 by 33.33%. In the same quarter last year, Intra-Cellular Therapies's earnings per share (EPS) was -$0.30. Intra-Cellular Therapies is expected to release next earnings on 07/07/2025, with an earnings per share (EPS) estimate of $0.